Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 8 | 2019 | 1426 | 1.710 |
Why?
|
| beta-Crystallin B Chain | 1 | 2019 | 2 | 0.730 |
Why?
|
| Pseudogenes | 1 | 2019 | 8 | 0.730 |
Why?
|
| Basement Membrane | 1 | 2019 | 28 | 0.720 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 166 | 0.700 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 70 | 0.690 |
Why?
|
| Silver | 1 | 2019 | 53 | 0.680 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 91 | 0.670 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 111 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 528 | 0.600 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 182 | 0.590 |
Why?
|
| Receptors, LDL | 1 | 2016 | 30 | 0.580 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 180 | 0.580 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 2128 | 0.570 |
Why?
|
| Mammary Glands, Animal | 2 | 2012 | 25 | 0.540 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 3 | 0.500 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 968 | 0.490 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 14 | 0.440 |
Why?
|
| Paracrine Communication | 1 | 2012 | 14 | 0.440 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 166 | 0.440 |
Why?
|
| Stromal Cells | 1 | 2012 | 45 | 0.430 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 72 | 0.420 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 756 | 0.400 |
Why?
|
| Carrier Proteins | 1 | 2012 | 287 | 0.390 |
Why?
|
| Fibroblasts | 1 | 2012 | 252 | 0.380 |
Why?
|
| Macrophages | 1 | 2012 | 431 | 0.330 |
Why?
|
| Cell Movement | 3 | 2019 | 545 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 781 | 0.320 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1149 | 0.300 |
Why?
|
| Obesity | 1 | 2015 | 965 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2019 | 70 | 0.280 |
Why?
|
| Mice | 5 | 2019 | 5668 | 0.270 |
Why?
|
| Animals | 7 | 2019 | 14307 | 0.260 |
Why?
|
| Female | 9 | 2019 | 19873 | 0.260 |
Why?
|
| Humans | 11 | 2019 | 34853 | 0.260 |
Why?
|
| Gene Expression | 2 | 2019 | 639 | 0.240 |
Why?
|
| Biopsy | 2 | 2014 | 151 | 0.230 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 102 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2019 | 140 | 0.170 |
Why?
|
| Mice, Nude | 1 | 2019 | 323 | 0.170 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2017 | 3 | 0.160 |
Why?
|
| Thiazoles | 1 | 2017 | 71 | 0.150 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 43 | 0.150 |
Why?
|
| Pyridines | 1 | 2017 | 113 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2017 | 112 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2017 | 143 | 0.150 |
Why?
|
| Claudins | 1 | 2014 | 8 | 0.120 |
Why?
|
| Lipolysis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2014 | 24 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2015 | 167 | 0.120 |
Why?
|
| Cricetulus | 1 | 2012 | 74 | 0.110 |
Why?
|
| Prolactin | 1 | 2012 | 59 | 0.110 |
Why?
|
| CHO Cells | 1 | 2012 | 107 | 0.110 |
Why?
|
| Glycosylation | 1 | 2012 | 92 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 207 | 0.110 |
Why?
|
| Milk, Human | 1 | 2012 | 29 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 126 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2012 | 12 | 0.110 |
Why?
|
| Cricetinae | 1 | 2012 | 217 | 0.110 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 42 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 39 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 88 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 89 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 859 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 269 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 430 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2012 | 309 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 485 | 0.100 |
Why?
|
| Protein Transport | 1 | 2012 | 286 | 0.100 |
Why?
|
| Cell Death | 1 | 2012 | 260 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 818 | 0.100 |
Why?
|
| Estrogens | 1 | 2012 | 190 | 0.100 |
Why?
|
| Exosomes | 1 | 2012 | 97 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2012 | 834 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 325 | 0.090 |
Why?
|
| Protein Binding | 1 | 2012 | 913 | 0.090 |
Why?
|
| Cytokines | 1 | 2012 | 569 | 0.080 |
Why?
|
| Diet | 1 | 2015 | 747 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2017 | 1802 | 0.080 |
Why?
|
| Risk Factors | 1 | 2014 | 3414 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 242 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2015 | 79 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 188 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 423 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 600 | 0.030 |
Why?
|
| Apoptosis | 1 | 2017 | 1317 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4012 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 6448 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 9642 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 11034 | 0.010 |
Why?
|